- Home
- Industry Reports
- Healthcare
- Healthcare IT
- North America Genetic Testing Market- Size, Outlook, Trends and Forecast (2024 – 2032)
Genetic Testing is also known as DNA testing that determines the bloodlines and the genetic diagnosis of vulnerabilities to inherited diseases. Progeny Testing, a form of genetic testing can be used to evaluate the quality of breeding stock. Genetic testing determines the genetic strengths and vulnerabilities of the species population.
North America Genetic Testing Market Share:
North America genetic testing market is segmented on the basis of the type which is further categorized into various testing categories in which Predictive and Presymptomatic Testing is higher in revenue specified in terms of Cancer Panel.
North America Genetic Testing Market Size:
The market share is expected to reach USD XX billion with a CAGR of XX% by 2024.
Concerning Genetic Testing Market, North America is having the highest size of the genetic testing and newborn screening testing is expected to have the lead role in the market during the forecast period.
North America Genetic Testing Market Growth:
The challenges like high cost of test and monetary obstructions due to the high cost of technology in production may hamper the growth of the market. The growing number of chronic diseases like cancer, Alzheimer’s etc. that drive the major growth in the market
North America Genetic Testing Market Industry Analysis:
North America Genetic Testing Market is segmented on the basis of Type which is further segmented into the newborn screening, carrier testing, prenatal testing, diagnostic testing, cancer testing, neonatal testing, predictive and presymptomatic testing.
North America Genetic Testing Market Outlook:
North America is expected to register the highest share of the genetic testing market due to the presence of key players like Genentech and Oxford Biomedical in the biotechnology industry. On the other hand, Asia Pacific is going to be the fastest growing region for the genetic testing market.
North America Genetic Testing Market Trends:
HHV7 ELITe MGB Kit is the product by ELITech Group that is used for the detection of the human herpesvirus 7 DNA and PCR amplification by BioRad Laboratories that is used to provide greater accuracy in nucleic acid amplification for genomic experiments.
North America Genetic Testing Market Research Report includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions.
- Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as
- ELITech Group
- AutoGenomics Inc.
- BioRad Laboratories
- Celera Group
- Transgenomic Inc.
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Type
6.1 Newborn Screening
6.2 Predictive and Presymptomatic Testing
6.3 Carrier Testing
6.4 Prenatal Testing
6.5 Diagnostic Testing
6.6 Cancer Testing
6.7 Neonatal Testing
Chapter 7 Market Segmentation by Geography
7.1 North America
7.2.1 Introduction
7.2.2 United States
7.2.3 Canada
7.2.4 Mexico
7.2.5 Others
Chapter 8 Competitive Landscape
8.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
8.2 Market Share Analysis
8.3 Strategies Adopted By Top Companies
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.1.1 Business Overview
9.1.2 Product portfolio
9.1.3 Key Strategy
9.1.4 Recent Developments
9.2 ELITech Group
9.3 AutoGenomics Inc.
9.4 BioRad Laboratories
9.5 Celera Group
9.6 Transgenomic Inc.
9.7 Quest Diagnostics Inc
9.8 PerkinElmer Inc
9.9 Applied Biosystems Inc.,
9.10 Roche Molecular Diagnostics Inc.
9.11 Ariosa Diagnostics, Inc.
9.12 Biohelix Corporation
9.13 Cepheid
9.14 Biomerieux S.A
9.15 Genentech, Inc
Chapter 10 Market Estimates and Forecast
10.1 Market Estimates and Forecast 2018-2024(USD Million)
10.1.1 Market Estimation and Forecast by Type 2018-2024 (USD Million)
10.1.2 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
Chapter 11 Market Insights
11.1 Insights of Industry Experts
11.2 Analyst Opinion (Market Understanding)
11.3 Investment Opportunities
Chapter 12 Appendix
12.1 List of Tables
12.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Regional Report
$2,160.00 – $7,200.00
- EUR: €1,991.88 - €6,639.62
- INR: ₹180,043.09 - ₹600,143.64
- AED: د.إ7,927.20 - د.إ26,424.00
- GBP: £1,706.75 - £5,689.16
Description
Regional Reports
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Genetic Testing is also known as DNA testing that determines the bloodlines and the genetic diagnosis of vulnerabilities to inherited diseases. Progeny Testing, a form of genetic testing can be used to evaluate the quality of breeding stock. Genetic testing determines the genetic strengths and vulnerabilities of the species population.
North America Genetic Testing Market Share:
North America genetic testing market is segmented on the basis of the type which is further categorized into various testing categories in which Predictive and Presymptomatic Testing is higher in revenue specified in terms of Cancer Panel.
North America Genetic Testing Market Size:
The market share is expected to reach USD XX billion with a CAGR of XX% by 2024.
Concerning Genetic Testing Market, North America is having the highest size of the genetic testing and newborn screening testing is expected to have the lead role in the market during the forecast period.
North America Genetic Testing Market Growth:
The challenges like high cost of test and monetary obstructions due to the high cost of technology in production may hamper the growth of the market. The growing number of chronic diseases like cancer, Alzheimer’s etc. that drive the major growth in the market
North America Genetic Testing Market Industry Analysis:
North America Genetic Testing Market is segmented on the basis of Type which is further segmented into the newborn screening, carrier testing, prenatal testing, diagnostic testing, cancer testing, neonatal testing, predictive and presymptomatic testing.
North America Genetic Testing Market Outlook:
North America is expected to register the highest share of the genetic testing market due to the presence of key players like Genentech and Oxford Biomedical in the biotechnology industry. On the other hand, Asia Pacific is going to be the fastest growing region for the genetic testing market.
North America Genetic Testing Market Trends:
HHV7 ELITe MGB Kit is the product by ELITech Group that is used for the detection of the human herpesvirus 7 DNA and PCR amplification by BioRad Laboratories that is used to provide greater accuracy in nucleic acid amplification for genomic experiments.
North America Genetic Testing Market Research Report includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions.
- Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as
- ELITech Group
- AutoGenomics Inc.
- BioRad Laboratories
- Celera Group
- Transgenomic Inc.
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Type
6.1 Newborn Screening
6.2 Predictive and Presymptomatic Testing
6.3 Carrier Testing
6.4 Prenatal Testing
6.5 Diagnostic Testing
6.6 Cancer Testing
6.7 Neonatal Testing
Chapter 7 Market Segmentation by Geography
7.1 North America
7.2.1 Introduction
7.2.2 United States
7.2.3 Canada
7.2.4 Mexico
7.2.5 Others
Chapter 8 Competitive Landscape
8.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
8.2 Market Share Analysis
8.3 Strategies Adopted By Top Companies
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.1.1 Business Overview
9.1.2 Product portfolio
9.1.3 Key Strategy
9.1.4 Recent Developments
9.2 ELITech Group
9.3 AutoGenomics Inc.
9.4 BioRad Laboratories
9.5 Celera Group
9.6 Transgenomic Inc.
9.7 Quest Diagnostics Inc
9.8 PerkinElmer Inc
9.9 Applied Biosystems Inc.,
9.10 Roche Molecular Diagnostics Inc.
9.11 Ariosa Diagnostics, Inc.
9.12 Biohelix Corporation
9.13 Cepheid
9.14 Biomerieux S.A
9.15 Genentech, Inc
Chapter 10 Market Estimates and Forecast
10.1 Market Estimates and Forecast 2018-2024(USD Million)
10.1.1 Market Estimation and Forecast by Type 2018-2024 (USD Million)
10.1.2 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
Chapter 11 Market Insights
11.1 Insights of Industry Experts
11.2 Analyst Opinion (Market Understanding)
11.3 Investment Opportunities
Chapter 12 Appendix
12.1 List of Tables
12.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.